Whereas variable associations were observed in maternal outcomes, PIH and insulin-treated patients, PROM and metformin-treated patients, eclampsia, and mothers not having GDM had significant associations, leading to the overall conclusion that metformin is a safer alternative for the treatment of GDM than insulin. This evidence concerns the gene INS and gestational diabetes.